Efficacy and safety of Qishen Yiqi dropping pills combined with modern medicine for coronary heart disease with ischemic heart failure: A systematic review and meta-analysis

医学 荟萃分析 出版偏见 漏斗图 科克伦图书馆 药丸 内科学 心力衰竭 优势比 冠状动脉疾病 置信区间 梅德林 心脏病学 药理学 政治学 法学
作者
Qiushan Man,Shi-Jian Chen,Xingyu Li
出处
期刊:Medicine [Wolters Kluwer]
卷期号:103 (44): e39927-e39927
标识
DOI:10.1097/md.0000000000039927
摘要

Background: Qishen Yiqi dropping pills combined with modern medicine have been widely used as a treatment for coronary heart disease with ischemic heart failure. Currently, there have been no robust studies addressing the efficacy and safety of Qishen Yiqi dropping pills combined with modern medicine for coronary heart disease with ischemic heart failure. Therefore, this systematic review and meta-analysis are conducted to fill in the gaps mentioned above. Methods: This systematic review was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Relevant studies published from inception to April 17, 2023, in the 5 electronic databases: PubMed, The Cochrane Library, EMBASE, CNKI, and the Wanfang database were comprehensively searched. Weighted mean difference was used as the effect size for the continuous variables. Pooled odd ratios are presented if the results are binary variables. Additionally, we performed subgroup and sensitivity analyses to examine the source of heterogeneity. The funnel plot and the Egger test were used to estimate publication bias. Results: This meta-analysis included 46 studies involving 5843 participants. There is a significant difference in clinical efficacy, the 6-minute walk test (weighted mean difference = 50.10; 95% CI 28.19 to 72.02; I2 = 98.9%, P = .000), the indexes of ultrasonic cardiogram, blood biochemical indexes, and adverse effects (odds ratios = 0.46; 95% CI 0.29 to 0.75; I2 = 35.9%, P = .142). The sensitivity analysis and publication bias have demonstrated the robustness of the results ( P = .702). Conclusion: Qishen Yiqi dropping pills combined with modern medicine could significantly improve clinical efficacy without incasement adverse effects. Further studies are required to identify the more comprise efficacy and safety results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
roy完成签到,获得积分10
1秒前
adi发布了新的文献求助10
1秒前
1秒前
快乐的青柏完成签到,获得积分10
2秒前
hanye完成签到 ,获得积分10
2秒前
大胆的夏天完成签到,获得积分10
4秒前
影子完成签到 ,获得积分10
6秒前
wonhui完成签到,获得积分20
8秒前
哈哈哈完成签到,获得积分10
11秒前
Orange应助yar采纳,获得10
12秒前
m7m发布了新的文献求助30
13秒前
球球完成签到,获得积分10
14秒前
坦率白萱应助空禅yew采纳,获得10
14秒前
迷路宛筠完成签到 ,获得积分10
16秒前
Liu应助kk采纳,获得50
17秒前
小二郎应助樱桃窝窝头采纳,获得10
18秒前
坚定小熊猫完成签到,获得积分20
22秒前
23秒前
23秒前
27秒前
陶淘淘完成签到,获得积分10
28秒前
量子星尘发布了新的文献求助10
28秒前
李健的小迷弟应助yar采纳,获得10
28秒前
30秒前
T123456789完成签到,获得积分10
30秒前
MPC完成签到,获得积分10
31秒前
MingqingFang发布了新的文献求助10
31秒前
肖肖发布了新的文献求助10
33秒前
单凝完成签到,获得积分10
34秒前
wyw完成签到 ,获得积分10
38秒前
一只学术小白完成签到,获得积分10
40秒前
烟花应助茸茸茸采纳,获得30
41秒前
Owen应助zwy109采纳,获得10
43秒前
43秒前
明朗完成签到 ,获得积分10
43秒前
李健应助达布妞采纳,获得10
46秒前
高高完成签到,获得积分10
46秒前
吴兰田完成签到,获得积分10
47秒前
49秒前
50秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988997
求助须知:如何正确求助?哪些是违规求助? 3531351
关于积分的说明 11253520
捐赠科研通 3269928
什么是DOI,文献DOI怎么找? 1804830
邀请新用户注册赠送积分活动 882063
科研通“疑难数据库(出版商)”最低求助积分说明 809068